MollyK was founded in 2012 in memory of Mradula “Molly” Kalathia who passed away from Idiopathic Pulmonary Fibrosis (IPF). MollyK’s mission is to raise Pulmonary Fibrosis (PF) awareness and support research efforts to find a cure. Annually, we organize events (5K & 1K Run/Walk) in the DC and Boston area in collaboration with the PF community and organizations. The MollyK events have raised over $90,000 with the proceeds benefiting the Pulmonary Fibrosis Foundation, Inova Fairfax Hospital, and the Coalition for Pulmonary Fibrosis.
Pulmonary Fibrosis affects up to 200,000 Americans and is a condition in which lung tissue becomes scarred, thickened, and stiff. The scarring is called fibrosis and makes it hard for a person to breathe. As a result, the brain, heart, and other vital organs may not get the oxygen they need to work properly. When there is no known cause for PF, the disease is called idiopathic pulmonary fibrosis (IPF). PF can strike anyone, but the disease tends to affect men more than women and usually occurs between the ages of 50 and 70. The most common symptoms are shortness of breath and a dry hacking cough. There is no cure for PF. Current treatments are aimed at preventing more lung scarring, relieving symptoms and helping patients stay active and healthy. These include US Food and Drug Administration (FDA) approved medications, oxygen therapy, pulmonary rehabilitation, and lung transplant. Some people stay in stable condition for years, while others may experience rapidly-worsening symptoms and overall health. The median survival rate is two to three years following diagnosis and more than two-thirds die within five years. An estimated 40,000 people die in the US each year from PF, around the same number attributed to breast cancer.Pulmonary Fibrosis FoundationView Here Every Breath Counts DocumentaryView Here Inova
Lung-TransplantView Here PF WarriorView Here Patients Like MeView Here